Pakistan is on the threshold of becoming the first country to carry out research, mandatory to introduce intravenous immunoglobulin (C-IVIG) therapy at a mass level as ‘severe’ patients under treatment for coronavirus, have 100% recovery rate.

Scientists at the Dow University of Health Sciences (DUHS) in Karachi, who are conducting clinical trials of the C-IVIG therapy for the treatment coronavirus, have said that the trials were very encouraging and remarkable.

The trials come as the country remains in the grip of a second and deadlier wave of coronavirus, which say 73 deaths and 2,459 new cases of the contagion in the last 24 hours, while the national positivity ration rising to more than 7%.

https://tribune.com.pk/story/2276088/pakistan-may-introduce-c-ivig-therapy-as-covid-continue-to-spread